Patents by Inventor Shuqian Jing

Shuqian Jing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibroblast growth factor-like molecules and uses thereof
    Publication number: 20020037557
    Abstract: The present invention provides Fibroblast Growth Factor-Like (FGF-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGF-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGF-L polypeptides.
    Type: Application
    Filed: March 13, 2001
    Publication date: March 28, 2002
    Applicant: Amgen, Inc.
    Inventors: Shuqian Jing, Michael Brian Bass
  • IL-17 like molecules and uses thereof
    Publication number: 20020037524
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: June 21, 2001
    Publication date: March 28, 2002
    Inventors: Eugene Medlock, Richard Yeh, Scott M. Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • EPH-like receptor protein tyrosine kinases
    Patent number: 5981245
    Abstract: Four novel members of the EPH sub-family of receptor protein tyrosine kinases are disclosed. Nucleic acid sequences encoding receptor proteins, recombinant plasmids and host cells for expression, and methods of producing and using such receptors are also disclosed.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: November 9, 1999
    Assignee: Amgen Inc.
    Inventors: Gary M. Fox, Andrew A. Welcher, Shuqian Jing
  • Nucleic acids encoding EPH-like receptor protein tyrosine kinases
    Patent number: 5981246
    Abstract: Four novel members of the EPH sub-family of receptor protein tyrosine kinases are disclosed. Nucleic acid sequences encoding receptor proteins, recombinant plasmids and host cells for expression, and methods of producing and using such receptors are also disclosed.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: November 9, 1999
    Assignee: Amgen Inc.
    Inventors: Gary M. Fox, Andrew A. Welcher, Shuqian Jing